Werewolf Therapeutics, Ambros Therapeutics Plan Merger With $150 Million Financing

Werewolf Therapeutics and Ambros Therapeutics have entered into a definitive all-stock merger agreement that would create a Nasdaq-listed, late-stage biotechnology... Read More

The post Werewolf Therapeutics, Ambros Therapeutics Plan Merger With $150 Million Financing appeared first on citybiz.